ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression
Author:
Publisher
Elsevier BV
Subject
Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)
Reference62 articles.
1. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program;Mirabello;Cancer,2009
2. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons;Mirabello;Int J Cancer,2009
3. A cadaveric comparative study on the surgical accuracy of freehand, computer navigation, and patient-specific instruments in joint-preserving bone tumor resections;Bosma;Sarcoma,2018
4. Tumor-infiltrating lymphocytes and cancer markers in osteosarcoma: influence on patient survival;Casanova;Cancers (Basel),2021
5. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Refining the role of N6-methyladenosine in cancer;Current Opinion in Genetics & Development;2024-10
2. N6-methyladenosine facilitates arsenic-induced neoplastic phenotypes of human bronchial epithelial cells by promoting miR-106b-5p maturation;Ecotoxicology and Environmental Safety;2024-09
3. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1;Biology Direct;2024-06-07
4. Novel Insights into the Links between N6-Methyladenosine and Regulated Cell Death in Musculoskeletal Diseases;Biomolecules;2024-04-24
5. Emerging role of N6-methyladenosine RNA modification in regulation of SARS-CoV-2 infection and virus-host interactions;Biomedicine & Pharmacotherapy;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3